Table 1 The expression of FSHR, CD34, and D2-40 in peritumoral vessels associated with invasive breast cancer
Marker immunostained vessels/mm 2 a | p-value | ||||||
|---|---|---|---|---|---|---|---|
Tumors | No of cases | FSHR | CD34 | D2-40 | FSHR vs. CD34 | FSHR vs. D2-40 | CD34 vs. D2-40 |
HR+/HER2- | 35 | 36.7 ± 4.0 | 100.4 ± 26 | 3.9 ± 3.7 | p < 0.001 | p > 0.05 | p < 0.01 |
HR+/HER2+ | 13 | 31.4 ± 5.2 | 92.4 ± 13.9 | 5.4 ± 4.7 | p < 0.001 | p > 0.05 | p = 0.01 |
HR-/HER2+ | 19 | 39.6 ± 6.0 | 84.3 ± 28.3 | 5.7 ± 1.9 | p < 0.001 | p > 0.05 | p = 0.01 |
TN | 16 | 38.4 ± 8.0 | 106.8 ± 13.4 | 7.9 ± 2.8 | p < 0.001 | p > 0.05 | p < 0.01 |